Arrayjet’s ArrayPlex platform selected by Immunome for use in its discovery of targeted cancer therapies Post author: Post published:March 18, 2024 Post category:uncategorized Immunome signs deal to use Arrayjet platform in its in-house screening operations. You Might Also Like Researchers uncover key genes linked to DCIS progression November 20, 2024 Scientists identify new trigger for autophagy September 23, 2024 Explosive Desantis-Newsom debate reflects nation’s culture wars December 1, 2023